Search research articles
Contact Us
Filters
Showing results (191-200 of 198) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 198 results.
The Journal of Clinical Endocrinology and Metabolism
|
September 11, 2001
The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer
J C Smith, S Bennett, L M Evans, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1983
Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect
M D Rodriguez-Arnao, J R Peters, S M Foord, et al.
European Journal of Endocrinology
|
March 4, 2000
The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency
L M Evans, J S Davies, R A Anderson, et al.
Clinical Endocrinology
|
February 1, 1990
Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases
D S Kiddy, P S Sharp, D M White, et al.
Molecular and Cellular Endocrinology
|
June 1, 2002
Loss of ACTH expression in cultured human corticotroph macroadenoma cells is consistent with loss of the POMC gene signal sequence
D A Rees, P J Hepburn, A M McNicol, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 20, 1998
Immortalized human pituitary cells express glycoprotein alpha-subunit and thyrotropin beta (TSH beta)
J Ham, J Webster, J A Bond, et al.
Journal of the Royal College of Physicians of London
|
October 1, 1988
The impact of guidelines in clinical outpatient practice
R Hall, C J Roberts, G A Coles, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 5, 2002
Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size
J S Bevan, S L Atkin, A B Atkinson, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 198) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 198 results.
The Journal of Clinical Endocrinology and Metabolism
|
September 11, 2001
The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer
J C Smith, S Bennett, L M Evans, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1983
Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect
M D Rodriguez-Arnao, J R Peters, S M Foord, et al.
European Journal of Endocrinology
|
March 4, 2000
The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency
L M Evans, J S Davies, R A Anderson, et al.
Clinical Endocrinology
|
February 1, 1990
Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases
D S Kiddy, P S Sharp, D M White, et al.
Molecular and Cellular Endocrinology
|
June 1, 2002
Loss of ACTH expression in cultured human corticotroph macroadenoma cells is consistent with loss of the POMC gene signal sequence
D A Rees, P J Hepburn, A M McNicol, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 20, 1998
Immortalized human pituitary cells express glycoprotein alpha-subunit and thyrotropin beta (TSH beta)
J Ham, J Webster, J A Bond, et al.
Journal of the Royal College of Physicians of London
|
October 1, 1988
The impact of guidelines in clinical outpatient practice
R Hall, C J Roberts, G A Coles, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 5, 2002
Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size
J S Bevan, S L Atkin, A B Atkinson, et al.
Page
of 20